Posted On: 12/01/2015 9:56:00 PM
Post# of 193
Valeant Stock Up 40% Since November 17
Valeant Pharmaceuticals International Inc. (NYSE:VRX & TSE:VRX) surged nearly 10% Tuesday, putting it on target for a three-day winning streak and helping the stock to recoup its losses over the past month.
Valeant Pharmaceuticals shares have gained about 40% since falling to a recent closing low of $70.32 on Nov. 17. The stock is now heavily Bullish.
The stock closed $98.78 on Tuesday after gaining nearly 10%.
The average price target for Valeant Pharmaceuticals (NYSE:VRX) is $172 according to NASDAQ Research. Latest NASDAQ’s investor sentiment is 85% BULLISH on VRX .
CNN Money analysts also maintains bullish forecast for Valeant Pharmaceuticals, with some price target reaching as high as $300
Continue reading at Stock Market Outlook
Valeant Pharmaceuticals International Inc. (NYSE:VRX & TSE:VRX) surged nearly 10% Tuesday, putting it on target for a three-day winning streak and helping the stock to recoup its losses over the past month.
Valeant Pharmaceuticals shares have gained about 40% since falling to a recent closing low of $70.32 on Nov. 17. The stock is now heavily Bullish.
The stock closed $98.78 on Tuesday after gaining nearly 10%.
The average price target for Valeant Pharmaceuticals (NYSE:VRX) is $172 according to NASDAQ Research. Latest NASDAQ’s investor sentiment is 85% BULLISH on VRX .
CNN Money analysts also maintains bullish forecast for Valeant Pharmaceuticals, with some price target reaching as high as $300
Continue reading at Stock Market Outlook
(0)
(0)
